Standard Lithium Breaks Ground for Its Direct Lithium Extraction Demonstration Plant
- Expected to Produce 100-150 Tonnes per Annum of Lithium Carbonate
- Lithium Included on List of Minerals Critical to U.S. National Security and the Economy
- Environmentally Friendly Faster Processing Time Higher Recovery than Traditional Extraction
EL DORADO, Ark., June 26, 2019 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLL) (OTCQX: STLHF) (FRA: S5L), today announced that it has broken ground in El Dorado Arkansas for its first-of-a-kind direct lithium extraction demonstration plant that selectively extracts lithium from the tail brine that is a by-product of the existing bromine production operations run by LANXESS.
The Demonstration Plant will employ the Company’s proprietary technology that uses a solid sorbent material to selectively extract lithium from LANXESS South Plant’s tailbrine. Designed to continuously process an input tailbrine flow of 50 gallons per minute (11.4 m3/hr), the plant is expected to achieve equivalent to an annual production of between 100 and 150 tonnes per annum Lithium Carbonate. The environmentally friendly process eliminates the use of evaporation ponds, reduces processing time from months to hours and greatly increases the effective recovery of lithium.
Dr Andy Robinson, Standard Lithium President and COO, commented “Standard Lithium is continuing to execute its disciplined development strategy. We are separating ourselves from our peers by partnering with a global chemical company with real operational experience, deploying demonstration-scale proof-of-concept technology at an operating brine-processing plant, and removing financing and off-take risks through our joint venture strategy. Ground-breaking at the site is a key step in realising our rapid development timelines, and we look forward to providing more updates as this phase of the project moves towards commissioning.”
The site, located at one of the operational brine processing plants (picture below), is currently being levelled and graded in preparation for construction of the foundations and concrete slabs needed to house the industrial-scale demonstration plant (see press release dated 2nd June 2019).
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3a1260c0-be39-4e3d-9820-88b78568b702
The work is being managed on-site by Hunt Guillot & Associates LLC (HGA) of Ruston, Louisiana, which has completed all the civil engineering and site utility connection works to date. HGA has been contracted to supervise and control all work related to the installation and connection of the modular Demonstration Plant at the operational brine facility, and El Dorado-based contractor Milam Construction will complete the majority of the work. Standard Lithium’s recently hired Plant Manager, Mr. Bruce Seitz, will also be present on-site during all enabling and installation works. The current schedule allows for pre-installation works to be completed prior to all the modules being mobilised to the site by the end of Q3, 2019.
Standard Lithium CEO Robert Mintak stated, “No new lithium mine has been built in the United States in over five decades; breaking ground at our El Dorado site represents a major achievement towards changing that. We anticipate our project and progress will be keenly watched as lithium has taken on significant political interest with the White House 2017 executive order and subsequent pending legislation aimed to boost domestic supplies of critical minerals.”
The Company recently announced the results of a Preliminary Economic Assessment (PEA) (see press release dated June 19th,2019). The PEA considers the production of battery-quality lithium carbonate through a phased build-out with production ramped up over 5 years to a total 20,900 tonnes per annum (tpa) with a total CAPEX estimate including 25% contingency on both direct and indirect capital costs of US $437 Million.
About Standard Lithium Ltd.
Standard Lithium (TSX: SLL) is a specialty chemical company focused on unlocking the value of existing large-scale US based lithium-brine resources. The company believes new lithium production can be brought on stream rapidly by minimizing project risks at selection stage (resource, political, geographic, regulatory & permitting), and by leveraging advances in lithium extraction technologies and processes. The Company’s flagship project is located in southern Arkansas, where it is engaged in the testing and proving of the commercial viability of lithium extraction from over 150,000 acres of permitted brine operations utilizing the Company’s proprietary selective extraction technology. The Company is also pursuing the resource development of over 30,000 acres of separate brine leases located in southwestern Arkansas and approximately 45,000 acres of mineral leases located in the Mojave Desert in San Bernardino County, California.
Standard Lithium is listed on the TSX Venture Exchange under the trading symbol “SLL”; quoted on the OTC - Nasdaq Intl Designation under the symbol “STLHF”; and on the Frankfurt Stock Exchange under the symbol “S5L”. Please visit the Company’s website at www.standardlithium.com.
LHA Investor Relations, Mary Magnani, (415) 433-3777, firstname.lastname@example.org
On behalf of the Board,
Standard Lithium Ltd.
Robert Mintak, CEO & Director
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain certain “Forward-Looking Statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. When used in this news release, the words “anticipate”, “believe”, “estimate”, “expect”, “target, “plan”, “forecast”, “may”, “schedule” and other similar words or expressions identify forward-looking statements or information. These forward-looking statements or information may relate to future prices of commodities, accuracy of mineral or resource exploration activity, reserves or resources, regulatory or government requirements or approvals, the reliability of third party information, continued access to mineral properties or infrastructure, fluctuations in the market for lithium and its derivatives, changes in exploration costs and government regulation in Canada and the United States, and other factors or information. Such statements represent the Company’s current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affections such statements and information other than as required by applicable laws, rules and regulations.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
FRO - Invitation to Q3 2019 Results Conference Call and Webcast19.11.2019 13:16:00 CET | Press release
Frontline Ltd.’s preliminary third quarter 2019 results will be released on Wednesday November 27 2019, and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m. U.S. Eastern Time). The results presentation will be available for download from the Investor Relations section at www.frontline.bm ahead of the conference call. In order to attend the conference call you may do one of the following: a. Webcast Go to the Investor Relations section at www.frontline.bm and follow the “Webcast” link. b. Conference Call Participant dial-in telephone numbers: Norway +47 2156 3162 Norway toll free 800 10392 UK +44 (0) 203 009 5710 UK Toll Free 0 800 376 7425 USA +1 917 720 0178 USA Toll Free 866 869 2321 Conference ID 5598374 Participants will be asked for their full name & Conference ID. A Q&A session will be held after the teleconference/webcast. Information on how to submit questions will be given at the beginning of the session. The presentation material which will be used in th
Oasmia offentliggör prospekt i samband med företrädesemission om cirka 399 MSEK samt uppdaterad information som återfinns i prospektet19.11.2019 13:00:00 CET | Pressemelding
EJ FÖR PUBLICERING, DISTRIBUTION ELLER OFFENTLIGGÖRANDE, DIREKT ELLER INDIREKT, HELT ELLER DELVIS, INOM ELLER TILL USA, AUSTRALIEN, HONGKONG, JAPAN, KANADA, NYA ZEELAND, SCHWEIZ, SINGAPORE, SYDAFRIKA ELLER NÅGON ANNAN JURISDIKTION DÄR SÅDAN PUBLICERING, DISTRIBUTION ELLER OFFENTLIGGÖRANDE SKULLE VARA I STRID MED GÄLLANDE REGLER ELLER KRÄVA YTTERLIGARE REGISTRERING ELLER ANDRA ÅTGÄRDER ÄN VAD SOM FÖLJER AV SVENSK RÄTT. Styrelsen i Oasmia Pharmaceutical AB (“Oasmia” eller ”Bolaget”) meddelande den 11 november 2019 om genomförandet av en nyemission av aktier med företrädesrätt för Oasmias befintliga aktieägare om cirka 399 MSEK ("Företrädesemissionen"). Bolaget har med anledning av Företrädesemissionen upprättat ett prospekt som idag godkänts och registrerats av Finansinspektionen. Offentliggörande av prospekt För fullständig information om Företrädesemissionen hänvisas till det prospekt som upprättats av Bolaget samt idag godkänts och registrerats av Finansinspektionen per dagens datum.
Oasmia publishes prospectus in connection with the rights issue of approximately SEK 399 million and updated information included in the prospectus19.11.2019 13:00:00 CET | Press release
Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, New Zealand, South Africa, Switzerland, Singapore, the United States or any other jurisdiction where such distribution of this press release would be subject to legal restrictions. This press release does not constitute an offer of any securities of Oasmia Pharmaceuticals AB (publ). See the section “IMPORTANT INFORMATION” below. The board of Oasmia Pharmaceutical AB (“Oasmia” or the “Company”) announced on 11 November 2019 to carry out a new issue of shares with preferential rights for Oasmia’s shareholders of approximately SEK 399 million (the “Rights Issue”). As a result of the Rights Issue, the Company has prepared a prospectus, which has been approved and registered by the Swedish Financial Supervisory Authority today. Publication of the prospectus For complete information on the Rights Issue, refer to the prospectus that has been prepared by Oasmia as well as appro
Medtronic Reports Second Quarter Financial Results19.11.2019 12:45:00 CET | Press release
Revenue of $7.7 Billion Increased 3.0% Reported and 4.1% Organic GAAP Diluted EPS of $1.01; Non-GAAP Diluted EPS of $1.31 Cash Flow from Operations of $1.9 Billion Grew 61%; Free Cash Flow of $1.6 Billion Grew 66% Company Raises FY20 EPS Guidance DUBLIN, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2020, which ended October 25, 2019. The company reported second quarter worldwide revenue of $7.706 billion, an increase of 3.0 percent as reported or 4.1 percent on an organic basis, which adjusts for a $97 million negative impact from foreign currency and a $16 million contribution from the company’s acquisition of Titan Spine, which is reported in the Spine division in the Restorative Therapies Group. As reported, second quarter GAAP net income and diluted earnings per share (EPS) were $1.364 billion and $1.01, respectively. As detailed in the financial schedules included through the link at the end of t
Avenir LNG collaborates with Golar Power on developing small-scale LNG distribution in Brazil19.11.2019 12:00:00 CET | Press release
London, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Avenir LNG Limited (“Avenir”) wishes to announce that it will collaborate with Golar Power Limited (“Golar Power”) in developing the small-scale LNG market in Brazil. Avenir’s second 7,500 cbm LNG Carrier will be used to deliver LNG to various ports across Brazil upon delivery. The vessel will also offer ship-to-ship bunkering capability as part of Avenir’s global multi-nodal bunkering solution; adding to the Colombian, Mediterranean and Malaysian nodes which the company currently offers. Commenting on the collaboration with Golar Power, Andrew Pickering, Chief Executive Officer of Avenir LNG Limited, said, “This is another step in our strategy where we are working closely with a shareholder in leveraging its FSRU platform to develop small-scale LNG distribution and bunkering in key developing markets.” Commenting on the collaboration with Avenir LNG, Eduardo Antonello, Chief Executive Officer of Golar Power Limited, said, “Accessing small-scal
Conversion factor for Exchange offer in SGB IL 3102 2019-11-1919.11.2019 11:03:00 CET | Press release
2019-11-19 Conversion factor SGB IL 3102/3109; 0.8381954 The conversion factor of SGB IL 3102/3109 indicates the amount of SGB IL 3102 that the SNDO will buy back for each SGB IL 3109 issued in the switch auction at November 19, 2019. For further information, please contact: The funding desk + 46 8 613 4780 Funding@riksgalden.se